Evidence map›Paper›PMID 37869469›Full record

ArticleTherapeutic advances in infectious disease

Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study.

Mateusz Bartoszewicz, Sławomir Lech Czaban, Klaudia Bartoszewicz, Damian Kuźmiuk, Jerzy Robert Ładny

Abstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mateusz BartoszewiczDepartment of Anaesthesiology and Intensive Care, Medical University of Bialystok, Malmeda, Bialystok, Podlaskie, 15-089, Poland.ORCID https://orcid.org/0000-0001-6455-6962
Sławomir Lech CzabanDepartment of Anaesthesiology and Intensive Care, Medical University of Bialystok, Bialystok, Poland.
Klaudia BartoszewiczDepartment of Clinical Immunology, Medical University of Bialystok, Bialystok, Poland.
Damian KuźmiukDepartment of Anaesthesiology and Intensive Care, Medical University of Bialystok, Bialystok, Poland.
Jerzy Robert ŁadnyDepartment of Emergency Medicine, Medical University of Bialystok, Bialystok, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear. Objective: We aimed to identify prevalent causative pathogens of BSI and related factors in critically ill patients with COVID-19. Design: This was a single-center, retrospective cohort study. Methods: We analyzed the clinical characteristics and outcomes of 201 ICU patients with COVID-19. Logistic regression analysis was conducted to identify factors associated with BSI occurrence. Furthermore, we identified the primary causative pathogens of BSIs. The study outcomes were death or ICU discharge. Results: Among the 201 included patients, 43 (21.4%) patients developed BSI. The mortality rate was non-significantly higher in the BSI group than in the BSI group (65.1% Conclusion: Elucidating the risk factors for and common pathogens of BSI can inform prompt management and prevention of BSIs.

Indexed as

bloodstream infectionsCOVID-19intensive care unit

Identifiers

PMID37869469
PMCPMC10590042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.